journal article·2020-09

Copper-mediated synergistic catalytic titanium dioxide nanofilm with nitric oxide generation and anti-protein fouling for enhanced hemocompatibility and inflammatory modulation

Lang Jiang, Hang Yao, Xiao Luo, Dan Zou, Congzhen Han, Chenjue Tang, Yuwei He, Ping Yang, Jiang Chen, Ansha Zhao, Nan Huang

Publisher page

Abstract

Abstract Nitric oxide (NO) has become a highly compelling therapeutic gas for treating vascular diseases due to its versatile functions to vascular responses. Currently, NO biomimetic materials are successfully established through loading catalyst (i.e., Se, Cu) with the vehicle to decompose endogenous NO donors in blood continuously. However, current NO biomimetic materials are susceptible to the non-specific protein fouling, resulting in undesired therapeutic inefficiency with the observation of attenuated or even blocked NO catalytic activities. Herein, we produced a multifunctional nanofilm with dual catalysis based on the vascular stent platform via simply doping one kind of metal (Cu) as cocatalyst into anatase TiO2 crystal. Beneficial synergistic interactions between two kinds of catalysis are reported in this work. The nanofilm surface is endowed with photoinduced super hydrophilic conversion and controlled NO catalytic release simultaneously. The super hydrophilic surface shows the excellent self-cleaning ability to resist protein fouling. Importantly, the maintenance of the protein-resistant surface can effectively improve the NO catalytic release and reduce inflammatory stimuli, contributing to enhanced hemocompatibility. The optimum doping amount of Cu (TiO2@Cu1, 0.77 wt.%) is determined through the characterization of adjustable photoinduced hydrophilic conversion and appropriate NO catalytic generation within the effective physiological concentration. After vascular implantation in rats, the TiO2@Cu1 nanofilms achieved elevated performances on antithrombosis, reducing the intima hyperplasia area and promoting rapid reendothelialization at 4 weeks. This study provides a valuable guideline for NO-biomimetic materials used for blood contact devices and paves the way for the surface modification for vascular implants.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Electrospun Nanofibers in Biomedical Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease10.1056/NEJM199408253310801 ↗
2. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis10.1038/nrcardio.2015.164 ↗
3. Restenosis, stent thrombosis, and bleeding complications: navigating between scylla and charybdis10.1016/j.jacc.2018.02.023 ↗
4. Nitric oxide and the immune response10.1038/ni1001-907 ↗
5. A guardian for vascular grafts?10.1021/cr200008n ↗
6. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein10.1161/01.RES.65.1.1 ↗
7. Nitric oxide donors for cardiovascular implant applications10.1002/smll.201200458 ↗
8. Polymer-Based nitric oxide therapies: recent insights for biomedical applications10.1002/adfm.201101707 ↗
9. Copper-Incorporated collagen/catechol film for in situ generation of nitric oxide10.1021/acsbiomaterials.5b00131 ↗
10. Spontaneous catalytic generation of nitric oxide from S-Nitrosothiols at the surface of polymer films doped with lipophilic copper(ii) complex10.1021/ja035775x ↗
11. Polymethacrylates with a covalently linked cuii–cyclen complex for the in situ generation of nitric oxide from nitrosothiols in blood10.1002/anie.200503588 ↗
12. Copper-based SURMOFs for nitric oxide generation: hemocompatibility, vascular cell growth, and tissue response10.1021/acsami.8b22731 ↗
13. Inflammation and restenosis in the stent era10.1161/01.ATV.0000037100.44766.5B ↗
14. Implant infections: adhesion, biofilm formation and immune evasion10.1038/s41579-018-0019-y ↗
15. Proteins, platelets, and blood coagulation at biomaterial interfaces10.1016/j.colsurfb.2014.09.040 ↗
16. Platelets and restenosis10.1016/S0735-1097(99)00596-3 ↗
17. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?10.1016/S0140-6736(96)09424-X ↗
18. Relationship between photocatalytic activity, hydrophilicity and self-cleaning effect of tio2/sio2 films10.1016/j.surfcoat.2004.02.022 ↗
19. Mechanically durable carbon nanotube−composite hierarchical structures with superhydrophobicity, self-cleaning, and low-drag10.1021/nn901509r ↗
20. Grafting hyaluronic acid onto gold surface to achieve low protein fouling in surface plasmon resonance biosensors10.1021/am502921z ↗
21. Light-induced amphiphilic surfaces10.1038/41233 ↗
22. Mini review on photocatalysis of titanium dioxide nanoparticles and their solar applications10.1016/j.nanoen.2013.04.002 ↗
23. Under-Oil switchable superhydrophobicity to superhydrophilicity transition on tio2 nanotube arrays10.1021/acsnano.7b05813 ↗
24. Structural color in porous, superhydrophilic, and self-cleaning sio2/tio2 bragg stacks10.1002/smll.200700084 ↗
25. Visible-Light photocatalysis in nitrogen-doped titanium oxides10.1126/science.1061051 ↗
26. Visible-light induced hydrophilicity on nitrogen-substituted titanium dioxide films10.1039/b302975a ↗
27. Reduction of copper oxides by UV radiation and atomic hydrogen studied by XPS10.1016/0378-5963(82)90134-9 ↗
28. Oxidation of polycrystalline copper thin films at ambient conditions10.1021/jp076981k ↗
29. Visible-Light-Sensitive photocatalysts: nanocluster-Grafted titanium dioxide for indoor environmental remediation10.1021/acs.jpclett.5b02041 ↗
30. Progress and promise of nitric oxide-releasing platforms10.1002/advs.201701043 ↗
31. Lei J.; Vodovotz Y.; Tzeng E.; Billiar T.R., Nitric oxide, a protective molecule in the cardiovascular system. Nitric oxide35(2013) 175–185, 10.1016/j.niox.2013.09.004.</bib10.1016/j.niox.2013.09.004 ↗
32. Cornwell, T.L.; Arnold, E.; Boerth, N.J.; Lincoln, T.M., Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. Cell Physiol.267(1994) C1405–C1413, 10.1152/ajpcell.1994.267.5.C1405.10.1152/ajpcell.1994.267.5.C1405 ↗
33. Francis, S.H.; Busch, J.L.; Corbin, J.D., cGMP-Dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev.62(2010) 525–563, 10.1124/pr.110.002907.10.1124/pr.110.002907 ↗
34. Isenberg, J.S.; Romeo, M.J.; Yu, C.; Yu, C.K.; Nghiem, K.; Monsale, J.; Rick, M.E.; Wink, D.A.; Frazier, W.A.; Roberts, D.D., Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood111(2008) 613–623, 10.1182/blood-2007-06-098392.10.1182/blood-2007-06-098392 ↗
35. Strategies to increase nitric oxide signalling in cardiovascular disease10.1038/nrd4623 ↗
36. Palmer, R.M.J.; Ferrige, A.G.; Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature327(1987) 524–526, 10.1038/327524a0.10.1038/327524a0 ↗
37. Biological responses in stented arteries10.1093/cvr/cvt115 ↗
38. Schiffrin, Ernesto L., Immune mechanisms in hypertension and vascular injury. Clin. Sci.126(2014) 267–274, 10.1042/CS20130407.10.1042/CS20130407 ↗
39. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. front